PVP magnetic nanospheres: Biocompatibility, in vitro and in vivo bleomycin release

被引:59
作者
Ding Guowei
Adriane, Kamulegeya
Chen, XingZai
Chen Jie
Liu Yinfeng
机构
[1] Tongji Univ Hosp, Shanghai 200092, Peoples R China
[2] Tongji Stomatol Hosp, Dept Oral & Maxillofacial Surg, Tongji, Peoples R China
[3] Hosp Taian Med Coll, Shandong, Peoples R China
[4] Shanghai Univ, Dept Chem Engn & Technol, Shanghai 201800, Peoples R China
[5] Shanghai Univ, Dept Polymer Mat, Shanghai 201800, Peoples R China
关键词
polyvinylpyrrolidone (PVP) hydrogel; nanospheres; magnetic micromolecules; magnetic guided drug delivery;
D O I
10.1016/j.ijpharm.2006.07.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To synthesize and characterize a magnetic micromolecular delivery system based on PVP hydrogel with polyvinyl alcohol (PVA) as the crosslinker. Methods: The microparticles were successfully prepared using 25 kGy Co-60 gamma-ray irradiation and characterized. Biocompatibility, in vitro and in vivo drug release tests were carried out. Results and discussion: Bleomycin was quantitatively released with in slightly over 8 h (hours) from the nanospheres containing 1 mg bleomycin while the time was longer for those containing 5 mg. On the other hand free bleomycin quantitatively passed through the dialysis baffle with in only 3.5 h. For both 5 and 1 mg of bound bleomycin, it took up to 2 h to reach peak concentration compared to 30 min for the free drug. Conclusion: The PVP hydrogel magnetic nanospheres exhibited passive drug release that could be exploited to enhance therapeutic efficacy. The present results indicate that PVP hydrogel based magnetic nanospheres have potential as drug carriers in magnetic guided chemotherapeutic drug delivery. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:78 / 85
页数:8
相关论文
共 36 条
[1]   Reevaluation of ethylene oxide hemolysis and irritation potential [J].
Anand, VP ;
Cogdill, CP ;
Klausner, KA ;
Lister, L ;
Barbolt, T ;
Page, BFJ ;
Urbanski, P ;
Woss, CJ ;
Boyce, J .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003, 64A (04) :648-654
[2]  
[Anonymous], 1990, CRITICAL REV KINETIC
[3]  
AOUIDA M, 2004, BIOCHEM J, V15, P47
[4]   Water-soluble amphotericin B-polyvinylpyrrolidone complexes with maintained antifungal activity against Candida spp. and Aspergillus spp. and reduced haemolytic and cytotoxic effects [J].
Charvalos, E ;
Tzatzarakis, MN ;
Van Bambeke, F ;
Tulkens, PM ;
Tsatsakis, AM ;
Tzanakakis, GN ;
Mingeot-Leclercq, MP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (02) :236-244
[5]   Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin C [J].
Cheung, RY ;
Ying, YM ;
Rauth, AM ;
Marcon, N ;
Wu, XY .
BIOMATERIALS, 2005, 26 (26) :5375-5385
[6]  
CHRISTOPH A, 2000, CANCER RES, V60, P6641
[7]  
FARAJ T, 2003, IJPT, V1, P24
[8]  
Galmarini Carlos M, 2003, Expert Rev Anticancer Ther, V3, P717, DOI 10.1586/14737140.3.5.717
[9]   Preparation of magnetic polybutylcyanoacrylate nanospheres encapsulated with aclacinomycin A and its effect on gastric tumor [J].
Gao, Hong ;
Wang, Ji-Yao ;
Shen, Xi-Zhong ;
Deng, Yong-Hui ;
Zhang, Wei .
WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (14) :2010-2013
[10]   Adenovirus mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer [J].
Gurnani, M ;
Lipari, P ;
Dell, J ;
Shi, B ;
Nielsen, LL .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (02) :143-151